Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

for
Primary Myelofibrosis, Secondary Myelofibrosis
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 70

Code: NCT04370301

Phase2, Recruiting

BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

for
Mortality Prediction
Location: Detroit MI
Sponsor: Henry Ford Health System

Sex: All

Age: 18+

Code: NCT07769151

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

for
Acute Myeloid Leukemia
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT07548983

Phase1, Recruiting

GAIP ASD Research Study

for
Autism Spectrum Disorder, Autism, ASD,
Location: Roswell GA
Sponsor: Greater Atlanta Integrative Pediatrics

Sex: All

Age: 3+

Code: NCT07622316

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

for
Mild Cognitive Impairment, Early Alzheimer's Disease, AD-MCI
Location: Miami FL
Sponsor: Bernard (Barry) Baumel

Sex: All

Age: 55 - 70+

Code: NCT07512362

Phase2, Recruiting

Horizon Two: HR NDMM (MMRC-100)

for
High Risk Newly Diagnosed Multiple Myeloma
Location: New York NY, Chapel Hill NC, Detroit MI, Atlanta GA,
Sponsor: Multiple Myeloma Research Consortium

Sex: All

Age: 18+

Code: NCT07053436

Phase2, Recruiting

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06815003

Phase2, Recruiting

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06905509

Phase2, Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

for
Multiple Myeloma, Newly Diagnosed, Multiple Myeloma (MM)
Location: Norfolk VA, Chapel Hill NC, Columbus OH, Birmingham AL,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 19+

Code: NCT06974786

Phase2, Recruiting

Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation

for
Immune Tolerance
Location: Madison WI, Palo Alto CA
Sponsor: Samuel Strober

Sex: All

Age: 18 - 65

Code: NCT03292445

Early_phase1, Recruiting

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

for
Leukemia, Inborn Errors of Metabolism,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 30

Code: NCT02356653

Early_phase1, Recruiting

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback

for
Hematologic Diseases
Location: Palo Alto CA
Sponsor: Porteus, Matthew, MD

Sex: All

Age: 0 - 45

Code: NCT04640987

Phase1, Recruiting

Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting

for
Infertility, Male, Cancer, Autoimmune Disorder
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Male

Age: 0+

Code: NCT04452305

Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

for
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 70+

Code: NCT05805605

Phase2, Recruiting

Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation

for
Primary Graft Failure, Secondary Graft Failure
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0+

Code: NCT02161783

Recruiting

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

for
Multiple Myeloma
Location: Minneapolis MN
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT03127761

Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

for
Chronic Granulomatous Disease
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 4 - 65

Code: NCT05463133

Phase1, Phase2, Recruiting

Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

for
Myelofibrosis
Location: Minneapolis MN
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 55+

Code: NCT02934477

Recruiting

Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

for
Chronic Kidney Diseases, Kidney Transplant
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06752577

Recruiting

What are stem cell clinical trials?

Stem cell clinical trials are research studies that explore the therapeutic potential of stem cells for treating a wide range of diseases and conditions. These trials investigate various types of stem cells, including embryonic stem cells, induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and adipose-derived stem cells. These trials aim to develop treatments for a wide range of conditions, such as cardiovascular diseases, neurological disorders, autoimmune diseases, orthopedic injuries, Alzheimer's disease, Crohn's disease and cancer.

Importance of clinical trials for stem cells

Clinical trials for stem cells are crucial for advancing regenerative medicine and offering hope for patients with conditions that are currently difficult to treat. These studies help to determine the safety, efficacy, and optimal use of stem cell therapies, potentially leading to breakthroughs in the treatment of chronic diseases, immune disorders, and injuries. They play a vital role in understanding how stem cells can be used to repair damaged tissues, treat malignancies, and improve patient outcomes.

Types of interventions studied in stem cells clinical trials

Eligibility and participation in stem cells clinical trials

How to enroll in a stem cell clinical trial